Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U G Lempert

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Medizinische Klinik (Munich, Germany : 1983)|April 15, 1991
[PTH-related protein (PTHrP) in serum of patients with tumor hypercalcemia]S H Scharla, M Pecherstorfer, U G Lempert, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|February 1, 1991
Osteolytic activity of Walker carcinosarcoma 256 is due to parathyroid hormone-related protein (PTHrP)S H Scharla, H W Minne, U G Lempert, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1990
Bone mass reduction after estrogen deprivation by long-acting gonadotropin-releasing hormone agonists and its relation to pretreatment serum concentrations of 1,25-dihydroxyvitamin D3S H Scharla, H W Minne, S Waibel-Treber, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Medizinische Klinik (Munich, Germany : 1983)|April 15, 1991
[PTH-related protein (PTHrP) in serum of patients with tumor hypercalcemia]S H Scharla, M Pecherstorfer, U G Lempert, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|February 1, 1991
Osteolytic activity of Walker carcinosarcoma 256 is due to parathyroid hormone-related protein (PTHrP)S H Scharla, H W Minne, U G Lempert, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1990
Bone mass reduction after estrogen deprivation by long-acting gonadotropin-releasing hormone agonists and its relation to pretreatment serum concentrations of 1,25-dihydroxyvitamin D3S H Scharla, H W Minne, S Waibel-Treber, et al.
Pageof 2